Third-line treatment decision-making for metastatic colorectal cancer: a cross-sectional survey of US community physicians
These findings highlight the third-line treatment preferences and prescribing patterns of community-based physicians who are actively treating patients with mCRC.
Authors
- Christopher Cann (ORCID: https://orcid.org/0000-0002-6960-6460)
- Tehseen Salimi
- Melina Taylor (ORCID: https://orcid.org/0000-0002-8038-0095)
- Malinda O’Donnell
- Nadeem Khan
- Sophia Zhao
Institutions
- Fox Chase Cancer Center (US)
- Taiho Oncology (United States) (US)
- Thermo Fisher Scientific (United States) (US)
Publication Details
- Journal
- The Oncologist
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1093/oncolo/oyag018
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00